553672-39-2

Usage

Uses

Used in Neurological Conditions:
BENZYL METHYLPIPERIDIN-4-YLCARBAMATE is used as a muscle relaxant and antispasmodic agent for conditions such as cerebral palsy, stroke, and other neurological diseases. It helps alleviate muscle spasticity and provides relief from the symptoms associated with these conditions.
Used in Alcohol Withdrawal Syndrome Treatment:
BENZYL METHYLPIPERIDIN-4-YLCARBAMATE is used as a therapeutic agent for the treatment of alcohol withdrawal syndrome. It has been studied for its potential to manage the symptoms and complications arising from alcohol withdrawal.
Used in Sedation:
BENZYL METHYLPIPERIDIN-4-YLCARBAMATE is used as a sedative agent due to its calming properties. It can be beneficial in situations where a reduction in anxiety or agitation is required, contributing to a more relaxed state for the patient.

Upstream product

• 147539-41-1 4-methylamino-piperidine-1-carboxylic acid tert-butyl ester 
• 501-53-1 benzyl chloroformate 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 847039-05-8 4-(((benzyloxy)carbonyl)(methyl)amino)piperidine-1-carboxylic acid tert-butyl ester 

Relevant academic research and scientific papers

Rational Design, Synthesis, and Pharmacological Characterization of Novel Ghrelin Receptor Inverse Agonists as Potential Treatment against Obesity-Related Metabolic Diseases

A new chemotype of ghrelin inverse agonists was discovered through chimeric design based on molecular scaffolds known as growth-hormone secretagogue receptor (GHSR) modulators but with divergent pharmacodynamic and pharmacokinetic properties. The structur

Substituted Benzamide Compounds

Substituted benzamide compounds corresponding to formula (I) in which R5, R6, R7, R8, a, b, c, d, t, D and X have defined meanings, a process for their preparation, pharmaceutical compositions comprising such compounds, and a method of using such compounds to treat pain and other conditions mediated at least in part via the bradykinin 1 receptor.

Substituted triazole derivatives as oxytocin antagonists

The present invention relates to substituted triazoles of formula (I), uses thereof, processes for the preparation thereof and compositions containing said compounds. These inhibitors have utility in a variety of therapeutic areas including sexual dysfunction.

Alpha 1a adrenergic receptor antagonists

This invention relates to certain novel compounds and derivatives thereof, their synthesis, and their use as alpha 1a adrenergic receptor antagonists. One application of these compounds is in the treatment of benign prostatic hyperplasia. These compounds are selective in their ability to relax smooth muscle tissue enriched in the alpha 1a receptor subtype without at the same time inducing hypotension. One such tissue is found surrounding the urethral lining. Therefore, one utility of the instant compounds is to provide acute relief to males suffering from benign prostatic hyperplasia, by permitting less hindered urine flow. Another utility of the instant compounds is provided by combination with a human 5-alpha reductase inhibitory compound, such that both acute and chronic relief from the effects of benign prostatic hyperplasia are achieved.